v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash $ 21,844 $ 12,181
Inventory, current portion 23,506 19,535
Other receivable 133,906 133,906
Convertible notes receivable, net of discount 30,500 30,500
Receivable from sale of Stemsation stocks, net
Investment in Stemsation stocks 17,600 17,600
Settlement receivables 160,084 160,084
Prepaid expenses and other current assets 62,282 35,332
Total current assets 499,424 459,583
Inventory, less current portion 93,790 99,170
Property and equipment, net 23,304 25,805
Total assets 616,518 584,558
Current liabilities:    
Accounts payable 844,858 853,581
Accrued expenses 2,236,748 2,186,283
Accrued payroll due to officers 1,913,850 1,854,802
Accrued interest to related parties 208,833 202,831
Due to officers 1,685,020 1,592,794
Derivative liabilities 983,952 960,382
Debt, net of discount, current portion 9,856,069 9,610,022
SBA notes payable, current portion 13,439 12,525
Total current liabilities 17,742,769 17,273,220
SBA notes payable, less current portion 135,730 136,644
Total liabilities 17,878,499 17,409,864
Commitments and Contingencies (Note 11)  
Stockholders’ deficit:    
Preferred stock, $0.001 par value, 20,000,000 shares authorized and 12,000,000 Series B Preferred shares authorized, issued and outstanding 12,000 12,000
Common stock, $0.001 par value, 12,000,000,000 shares authorized; 7,159,727,214 and 7,099,727,214 shares issued and outstanding, respectively 7,159,727 7,099,727
Common stock to be issued 512,678 501,678
Additional paid-in capital 53,791,818 53,839,818
Accumulated deficit (78,738,204) (78,278,529)
Total stockholders’ deficit (17,261,981) (16,825,306)
Total liabilities and stockholders’ deficit 616,518 584,558
Nonrelated Party [Member]    
Current assets:    
Accounts receivable 26,345 26,060
Related Party [Member]    
Current assets:    
Accounts receivable $ 23,357 $ 24,385